@FiercePharma: Top-read on FierceAnimalHealth Monday: Merck releases tilapia vaccine. Article | Follow @FiercePharma
@EricPFierce: Boehringer Ingelheim opens a $30M packaging plant for its Vetmedica animal health biz. FierceAnimalHealth story | Follow @EricPFierce
@CarlyHFierce: Great news for those who have always wanted to hear me moderate a webinar: You're getting another chance. Register | Follow @CarlyHFierce
> Canada-based Apotex failed to persuade arbitrators that the FDA violated the North American Free Trade Agreement when it barred imports from two of the company's plants in Ontario. Release
> Philadelphia-based Iroko Pharmaceuticals won FDA approval for a new use for its nonsteroidal anti-inflammatory drug, Zorvolex, for osteoarthritis pain. Release
> Vivus ($VVUS), which sells the weight loss drug Qsymia, bought patents covering one of the drug's ingredients, topiramate, from Johnson & Johnson's ($JNJ) Janssen unit. Report
> India's Torrent Pharmaceuticals won exemptions from domestic price controls for two of its drugs, sending its shares soaring. Report
> Merck ($MRK) signed up for a training program to teach its employees to save energy. Report
Medical Device News
@FierceMedDev: ICYMI yesterday: Chinese physicians implant first 3-D printed vertebrae in child. Article | Follow @FierceMedDev
@VarunSaxena2: RT @FierceMedicalDevices: FDA simplifies approval process for innovative devices lacking a predecessor. Story | Follow @VarunSaxena2
@EmilyWFierce: Richard III was a foodie, according to a recent chemical analysis of the medieval king's teeth. NYT story | Follow @EmilyWFierce
> Researchers develop implant/app combo to monitor glaucoma in aging eyes. Story
> Philips Lifeline adds emergency response app to its service. Article
> Medtronic snags FDA approval for next-generation pacemaker. Report
Biotech News
@FierceBiotech: Banking on its R&D rep, Calithera looks to raise $80M in IPO. News | Follow @FierceBiotech
@JohnCFierce: Kite Pharma soars on early evidence that CAR-T treatment quells cancer. Report | Follow @JohnCFierce
@EmilyMFierce: Cubist exec: Challenges mount in antibiotics discovery. FierceBiotech Research report | Follow @EmilyMFierce
> Pfizer and Merck extend heavyweight immuno-oncology pact to lung cancer. More
> Civitas nails $55M venture round for a PhIII Parkinson's study. Story
> Alkermes closer to launching once-monthly schizophrenia drug into a crowded market. Article
Biotech Research News
> Cubist exec: Challenges mount in antibiotics discovery. Editor's Corner
> Tuberculosis biomarker predicts protection against disease symptoms. Article
> Scientists engineer opiate pain medicine without using poppies. Story
> Thymus gland grown from reprogrammed cells in lab. More
> Study: Early barriers in drug development are widespread. Report
Pharma Manufacturing News
> Sources: Ranbaxy's manufacturing problems lead to Texas. News
> Lupin took hard look at troubled Wockhardt for possible bid. More
> Alexion gets new Form 483 in follow-up inspection. Article
> Lonza looks to biotech funders for entree to business. Story
> Teva recalls Parkinson's disease drug because it may be 'superpotent.' Report
> PSC buys high-potency fill-finish facility from U.S. research group. Item
And Finally... Cancer survival rates are rising in the U.K., according to a government study. Report